Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000945330 | SCV001091325 | likely benign | Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome | 2023-12-26 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818923 | SCV002069727 | benign | not specified | 2018-08-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000945330 | SCV002524741 | benign | Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002547173 | SCV003703954 | likely benign | Inborn genetic diseases | 2021-11-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004705945 | SCV005224743 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003913195 | SCV004737087 | likely benign | AFF4-related disorder | 2021-06-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |